The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009–10 Seasonal Trivalent Inactivated Influenza Vaccination in Children
Background There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6–8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history. Methods and Findings We conducted a randomized controlled trial of 2009–10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9–17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6–8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6–8 y of age regardless of vaccination history. Conclusions Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.
References
[1]
Seidman JC, Richard SA, Viboud C, Miller MA (2012) Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respi Viruses 6: 52–62.
[2]
Wright PF, Sannella E, Shi JR, Zhu Y, Ikizler MR, et al. (2008) Antibody responses after inactivated influenza vaccine in young children. Pediatr Infect Dis J 27: 1004–1008.
[3]
Hobson B, Curry RL (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg 70: 767–777.
[4]
Coudeville L, Bailleux F, Riche B, Megas F, Andre P, et al. (2010) Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 10: 18.
Huijskens E, Rossen J, Mulder P, van Beek R, van Vugt H, et al. (2011) Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. Clin Vaccine Immunol 18: 1401–1405.
[7]
Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, et al. (2007) Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. J Med Virol 79: 320–325.
[8]
Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD (1999) Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med 159: 182–188.
[9]
Gross PA, Sperber SJ, Donabedian A, Dran S, Morchel G, et al. (1999) Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization. Vaccine 17: 2284–2289.
[10]
Gardner EM, Bernstein ED, Dran S, Munk G, Gross P, et al. (2001) Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 19: 4610–4617.
[11]
Bernstein DI, Yan L, Treanor J, Mendelman PM, Belshe R (2003) Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Pediatr Infect Dis J 22: 28–34.
[12]
Iorio AM, Camilloni B, Basileo M, Neri M, Lepri E, et al. (2007) Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. Gerontology 53: 411–418.
[13]
Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, et al. (2007) Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J 26: 107–115.
[14]
Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, et al. (2008) Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 3: e2975.
[15]
Michiels B, Philips H, Coenen S, Denekens J, Van Royen P (2006) Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002–2003). Vaccine 24: 3145–3152.
[16]
Howells CHL, Vesselinova CK, Evans AD, James J (1975) Influenza Vaccination and Mortality from Bronchopneumonia in Elderly. Lancet 1: 381–383.
[17]
Beyer WEP, Palache AM, Sprenger MJW, Hendriksen E, Tukker JJ, et al. (1996) Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 14: 1331–1339.
[18]
deBruijn IA, Remarque EJ, Beyer WEP, leCessie S, Masurel N, et al. (1997) Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 15: 1323–1329.
[19]
de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, et al. (1999) Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 179: 31–36.
[20]
Keitel WA (2002) Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy. Semin Pediatr Infect Dis 13: 112–119.
[21]
Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD (1998) The plea against annual influenza vaccination? ‘The Hoskins’ Paradox’ revisited. Vaccine 16: 1929–1932.
[22]
Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR (1997) Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15: 1114–1122.
[23]
Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, et al.. (2013) Influenza Vaccine Effectiveness in the Community and the Household. Clin Infect Dis In Press.
[24]
Centers for Disease Control and Prevention (2012) Prevention and control of influenza with vacines: recommenations of the advisory committee on immunization practices (ACIP) - United States, 2012–13 influenza season. Morbidity and mortality weekly report 61: 613–618.
[25]
Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, et al. (2005) Effectiveness of the 2003–2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116: 153–159.
[26]
Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, et al. (2006) Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 194: 1032–1039.
[27]
Cowling BJ, Ng S, Ma ES, Cheng CK, Wai W, et al. (2010) Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 51: 1370–1379.
[28]
Cowling BJ, Ng S, Ma ES, Fang VJ, So HC, et al. (2012) Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis 55: 695–702.
[29]
Ng S, Fang VJ, Ip DK, Chiu SS, Leung GM, et al. (2012) Humoral antibody response after receipt of inactivated seasonal influenza vaccinations one year apart in children. Pediatr Infect Dis J 31: 964–969.
[30]
Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL (2007) Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 119: 1076–1082.
[31]
Cowling BJ, Ng S, Ma ESK, Fang VJ, So HC, et al.. (2012) Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis in press.
[32]
Molenberghs G, Kenward MG (2007) Missing data in clinical studies (Statistics in practice). Chichester; Hoboken, NJ: Wiley.
[33]
Little R, An HG (2004) Robust likelihood-based analysis of multivariate data with missing values. Statistica Sinica 14: 949–968.
[34]
Van Buuren S, Brand JPL, Groothuis-Oudshoorn CGM, Rubin DB (2006) Fully conditional specification in multivariate imputation. J Stat Comp Sim 76: 1049–1064.
[35]
de Groot JA, Janssen KJ, Zwinderman AH, Moons KG, Reitsma JB (2008) Multiple imputation to correct for partial verification bias revisited. Stat Med 27: 5880–5889.
[36]
Osterholm MT, Kelley NS, Sommer A, Belongia EA (2011) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 36–44.
[37]
Fox JP, Cooney MK, Hall CE, Foy HM (1982) Influenzavirus infections in Seattle families, 1975–1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 116: 228–242.
[38]
Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, et al. (2011) Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 30: 1081–1085.
[39]
Pica N, Hai R, Krammer F, Wang TT, Maamary J, et al. (2012) Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America 109: 2573–2578.
[40]
Brown F, International Association for Biologicals, Universitetet i Bergen (2003) Laboratory correlates of immunity to influenza–A reassessment : University of Bergen, Bergen, Norway, 2–3 May, 2002, proceedings of a scientific workshop. Basel; New York: Karger. xi, 157 p. p.
[41]
World Health Organization (2007) Recommended composition of influenza virus vaccines for use in the 2007–2008 influenza season.
[42]
World Health Organization (2008) Recommended composition of influenza virus vaccines for use in the 2008–2009 influenza season.
[43]
WHO Influenza Centre (2009) Report. London: National Institute for Medical Research.
[44]
World Health Organization (2009) Recommended composition of influenza virus vaccines for use in the 2009–2010 influenza season.
